Vor Biopharma Inc (VOR)
1.80
+0.04
(+2.27%)
USD |
NASDAQ |
May 03, 16:00
1.80
0.00 (0.00%)
After-Hours: 07:35
Vor Biopharma Accounts Payable (Quarterly): 0.815M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 0.815M |
September 30, 2023 | 1.309M |
June 30, 2023 | 1.648M |
March 31, 2023 | 3.216M |
December 31, 2022 | 1.772M |
September 30, 2022 | 0.824M |
June 30, 2022 | 1.268M |
March 31, 2022 | 1.255M |
Date | Value |
---|---|
December 31, 2021 | 1.545M |
September 30, 2021 | 1.957M |
June 30, 2021 | 2.369M |
March 31, 2021 | 2.406M |
December 31, 2020 | 2.361M |
September 30, 2020 | 2.321M |
December 31, 2019 | 0.693M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.693M
Minimum
Dec 2019
3.216M
Maximum
Mar 2023
1.717M
Average
1.648M
Median
Jun 2023
Accounts Payable (Quarterly) Benchmarks
Masimo Corp | 251.50M |
AnaptysBio Inc | 4.698M |
Apellis Pharmaceuticals Inc | 37.52M |
NovaBay Pharmaceuticals Inc | 1.13M |
Palatin Technologies Inc | 1.594M |